Edward Loftus
Mayo Foundation for Medical Education and Research
Appearances
DateMay 7, 2023In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…Presenter
Mayo Foundation for Medical Education and Research- DateMay 7, 2023In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
Presenters
Mayo ClinicUniversity of California san franciscoMayo Foundation for Medical Education and ResearchMassachusetts General Hospital 
DateMay 6, 2023Handout [https://ddw.digitellinc…Presenters
University of Miami Miller School of MedicineMayo Foundation for Medical Education and ResearchBrigham and Women's Hospital- DateMay 6, 2023
Speakers
University of Miami Miller School of MedicineMayo Foundation for Medical Education and Research - DateMay 19, 2024
Presenters
Mayo Foundation for Medical Education and ResearchUniversity of California Los Angeles 
DateMay 18, 2024CARING FOR CHILDREN AND YOUNG ADULTS WITH AUTOIMMUNE LIVER DISEASE AND IBDModerators
Mayo Foundation for Medical Education and ResearchMayo Clinic RochesterSpeakers
University of Chicago Division of the Biological Sciences- DateMay 21, 2024BACKGROUND: Risankizumab (RZB), a monoclonal antibody targeting interleukin-23 p19, was evaluated for maintenance therapy in patients with moderately to severely active ulcerative colitis (UC) and clinical response to RZB intravenous (IV) induction treatment in a phase 3 double-blind, placebo (PBO)…
Presenter
Speakers
Mayo Foundation for Medical Education and Research 
DateMay 18, 2024MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIESModerators
Vanderbilt University Medical CenterMayo Foundation for Medical Education and Research
